Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
1.019 EUR | +0.99% | -2.77% | -1.16% |
Mar. 14 | Pharming Group N.V. Provides Earnings Guidance for the Year 2024 | CI |
Mar. 14 | Pharming Group Seeks Acquisitions | CI |
Chart calendar Pharming Group N.V.
Upcoming events on Pharming Group N.V.
Past events on Pharming Group N.V.
2024-03-14 08:30 am | Q4 2023 Earnings Call |
2024-03-14 02:00 am | Q4 2023 Earnings Release |
2024-02-27 | UBS European Healthcare Conference |
2024-02-27 | Morgan Stanley European MedTech and Life Sciences Conference |
2024-02-13 11:20 am | Oppenheimer Healthcare Life Sciences Conference |
2023-11-14 08:35 am | Stifel Healthcare Conference |
2023-11-14 03:30 am | Jefferies London Healthcare Conference |
2023-11-12 03:15 pm | American College of Allergy, Asthma & Immunology Scientific Meeting - Poster #M150 |
2023-11-11 03:35 pm | American College of Allergy Asthma & Immunology Scientific Meeting - Poster #P166 |
2023-11-11 03:20 pm | American College of Allergy Asthma & Immunology Scientific Meeting - Poster #P165 |
2023-11-10 06:00 pm | American College of Allergy Asthma & Immunology Scientific Meeting - Poster #M234 |
2023-11-10 09:15 am | International Primary Immunodeficiencies Congress - Poster #152 |
2023-11-09 04:00 am | International Primary Immunodeficiencies Congress - Poster #214 |
2023-11-09 02:00 am | International Primary Immunodeficiencies Congress - Poster #204 |
2023-10-26 07:30 am | Q3 2023 Earnings Call |
2023-10-26 01:00 am | Q3 2023 Earnings Release |
2023-09-28 10:20 am | Cantor Global Healthcare Conference |
2023-09-25 08:00 am | Extraordinary Shareholders Meeting |
2023-09-13 08:30 am | H.C. Wainwright Global Investment Conference |
2023-09-07 04:30 pm | Wells Fargo Healthcare Conference |
Annual results
Fiscal Period | December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
Net sales Million EUR | Released Forecast Spread | 135 136 -0.88% | 169 170 -0.71% | 186 184 1.18% | 181 178 1.35% | 195 194 0.35% | 224 226 -0.84% |
EBITDA Million EUR | Released Forecast Spread | 44,6 46,0 -3.07% | 66,1 61,7 7.16% | 75,7 74,8 1.25% | 51,4 43,5 17.99% | 29,8 30,1 -0.88% | 9,63 2,48 288.33% |
EBIT Million EUR | Released Forecast Spread | 38,0 43,4 -12.54% | 60,9 57,0 6.91% | 67,4 69,4 -2.89% | 33,5 25,7 30.56% | 17,3 22,6 -23.39% | -4,92 -7,59 35.12% |
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | 0,86 20,2 -95.76% | 46,7 42,3 10.24% | 39,3 44,7 -12.05% | 21,0 25,2 -16.8% | 14,2 43,0 -66.93% | -11,0 -5,14 -113.56% |
Net income Million EUR | Released Forecast Spread | 25,0 21,4 16.71% | 36,2 30,3 19.58% | 32,7 31,5 3.61% | 14,5 17,1 -15.09% | 13,0 33,7 -61.53% | -9,25 -3,75 -146.33% |
EPS EUR | Released Forecast Spread | 0,04 0,03 13.57% | 0,05 0,05 13.68% | 0,05 0,05 -5.44% | 0,02 0,05 -56.17% | 0,00 0,00 - | 0,00 -0,01 - |
Announcement Date | 07/03/19 | 05/03/20 | 04/03/21 | 17/03/22 | 16/03/23 | 14/03/24 |
Quarterly results
Fiscal Period | December | 2019 S1 | 2020 S1 | 2021 Q2 | 2021 S1 | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 S1 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 S1 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 S1 | 2024 Q3 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million EUR | Released Forecast Spread | 77,9 75,4 3.35% | 88,6 101 -12.28% | 41,3 47,6 -13.37% | 78,7 84,4 -6.7% | 45,6 46,2 -1.21% | 62,4 50,8 22.95% | 44,2 44,3 -0.18% | 49,0 50,8 -3.46% | 94,6 95,6 -1.11% | 53,9 53,6 0.46% | 51,8 54,0 -3.99% | 38,8 44,7 -13.32% | 50,2 48,4 3.79% | 89,1 88,0 1.24% | 63,0 56,3 11.85% | 64,3 | 66,1 | 66,1 | ||
EBIT Million EUR | Released Forecast Spread | 9,18 16,8 -45.35% | 9,74 11,2 -13.13% | 7,61 3,97 91.58% | 17,4 5,93 193.71% | 7,71 1,51 411.74% | -9,66 0,81 -1289.41% | -12,4 -0,19 -6591.93% | 4,85 -0,80 709.22% | 1,79 -1,54 216.54% | -3,76 | 1,88 | -1,99 | 54,9 | |||||||
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | 18,7 19,9 -6.22% | 25,9 26,3 -1.54% | 6,11 11,6 -47.53% | 16,9 22,5 -24.91% | 1,14 6,40 -82.18% | 3,58 3,81 -5.86% | 4,02 -3,09 229.77% | 19,1 6,63 188.3% | 23,3 10,4 124.23% | 9,22 5,14 79.32% | -17,2 6,36 -369.94% | -15,2 -3,03 -400.66% | 3,10 -7,03 144.05% | -12,2 -24,5 50.31% | 3,12 -8,16 138.19% | 5,24 | 6,85 | 5,37 | 22,0 | 29,8 |
Net income Million EUR | Released Forecast Spread | 13,6 13,8 -1.49% | 18,1 17,8 1.93% | 4,92 9,11 -45.96% | 12,1 16,4 -25.92% | -0,36 3,68 -109.81% | 3,21 2,75 16.91% | 3,28 -4,50 172.97% | 15,3 5,45 181.39% | 18,8 8,84 112.46% | 9,04 2,42 274.25% | -13,9 3,86 -459.83% | -11,1 -3,85 -189.1% | 1,21 -10,4 111.6% | -9,96 -26,4 62.25% | 3,31 -8,68 138.07% | 4,15 | 6,03 | 4,55 | 18,7 | 28,9 |
EPS EUR | Released Forecast Spread | 0,02 0,02 -4.76% | 0,03 0,02 4.17% | 0,01 0,01 -43.67% | 0,02 0,02 -33.13% | 0,00 0,00 -128.67% | 0,01 0,01 158.2% | ||||||||||||||
Announcement Date | 25/07/19 | 30/07/20 | 05/08/21 | 05/08/21 | 28/10/21 | 17/03/22 | 12/05/22 | 04/08/22 | 04/08/22 | 27/10/22 | 16/03/23 | 11/05/23 | 03/08/23 | 03/08/23 | 26/10/23 | - | - | - | - | - |
Past sector events for Pharming Group N.V.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock
- Equities
- Stock Pharming Group N.V. - Euronext Amsterdam
- Calendar Pharming Group N.V.